Filing Details

Accession Number:
0001104659-22-067762
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-06-02 20:02:55
Reporting Period:
2022-05-31
Accepted Time:
2022-06-02 20:02:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1425205 Iovance Biotherapeutics Inc. IOVA () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1363984 D Ryan Maynard C/O Iovance Biotherapeutics, Inc.
825 Industrial Road, 4Th Floor
San Carlos CA 94070
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-31 7,500 $6.75 7,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct